SYNGENE INTERNATIONAL LTD (SYNGENE) financials — quarterly results, P&L, cash flow, balance sheet, shareholding
Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be an integrated service provider offering end-to-end drug discovery, development, and manufacturing services on a single platform (CRAMS). Total research & manufacturi…
Syngene International Ltd
SYNGENE
Market Cap₹16,270Cr.
Current Price₹403
High / Low₹729/380
Stock P/E45.2
Book Value₹117
Dividend Yield0.31%
ROCE9.91%
ROE7.71%
Face Value₹10.0
Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be an integrated service provider offering end-to-end drug discovery, development, and manufacturing services on a single platform (CRAMS). Total research & manufacturing infrastructure for the company is spread across 1.9 million square feet across locations.[1]
Quarterly Results
Yearly Results
Shareholding Pattern
Shareholding Trend
Balance Sheet
Cash Flows
Last updated at: 24 July 2026 at 9:49:17